HT
AVXL icon

HAP Trading’s Anavex Life Sciences AVXL Stock Holding History

HAP Trading’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,900
Closed -$68K – 1731
2022
Q2 		$68K Sell
11,900
-6,200
-34% -$58.7K ﹤0.01% 979
2022
Q1 		$72K Sell
18,100
-7,700
-30% -$94.7K ﹤0.01% 1138
2021
Q4 		$123K Buy
25,800
+8,200
+47% +$156K ﹤0.01% 1166
2021
Q3 		$92K Buy
17,600
+6,200
+54% +$123K ﹤0.01% 1276
2021
Q2 		$9K Buy
+11,400
New +$169K ﹤0.01% 2014
2020
Q2 		– Sell
-11,000
Closed -$22K – 1680
2020
Q1 		$22K Buy
+11,000
New +$38.3K ﹤0.01% 912

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $1.74B AUM 32.48% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return